Firazyr and Magnesium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Firazyr (icatibant acetate) and Magnesium (magnesium). Common drug interactions include hereditary angioedema among females and hereditary angioedema among males.

The phase IV clinical study analyzes what interactions people have when they take Firazyr and Magnesium. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Firazyr?

Firazyr has active ingredients of icatibant acetate. eHealthMe is studying from 5,650 Firazyr users. Check the latest studies of Firazyr.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,144 Magnesium users. Check the latest studies of Magnesium.



On Jul, 05, 2026

90 people who take Firazyr and Magnesium together, and have interactions are studied.

Firazyr and Magnesium drug interactions.

What are the common drug interactions of Firazyr and Magnesium, by gender? *:

female:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Drug ineffective
  3. Thrombosis (formation of a blood clot inside a blood vessel)
  4. Road traffic accident
  5. Hospitalisation
  6. Weight decreased
  7. Irritable bowel syndrome
  8. Vomiting
  9. Weight increased
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

male:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Asthenia (weakness)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Dehydration (dryness resulting from the removal of water)
  5. Gait disturbance
  6. Hypotension (abnormally low blood pressure)
  7. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  8. Myalgia (muscle pain)
  9. Pain
  10. Pneumonia

What are the common drug interactions of Firazyr and Magnesium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Aspartate aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Blood cholesterol decreased
  5. Haemoglobin decreased

40-49:

  1. Heart rate increased
  2. Muscle contractions involuntary (uncontrolled muscle contraction)
  3. Pneumonia
  4. Intestinal perforation (complete penetration of the wall of the intestine)
  5. Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
  6. Asthma
  7. Drug ineffective
  8. Influenza
  9. Kidney infection
  10. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)

50-59:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Drug ineffective
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypersensitivity
  5. Injection site erythema (redness at injection site)
  6. Injection site pain
  7. Laryngeal oedema (swelling of larynx)
  8. Rash
  9. Stridor
  10. Swelling face

60+:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Irritable bowel syndrome
  3. Fibromyalgia (a long-term condition which causes pain all over the body)
  4. Headache (pain in head)
  5. Influenza
  6. Poor quality sleep
  7. Abdominal hernia
  8. Abnormal weight gain
  9. Allergy to plants
  10. Arthralgia (joint pain)

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 66 people, 73.33%
  2. Immune System Disorder: 38 people, 42.22%
  3. Asthma: 7 people, 7.78%
  4. Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 6 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Firazyr and Magnesium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Firazyr and Magnesium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Firazyr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Magnesium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Firazyr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Magnesium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on icatibant acetate and magnesium (the active ingredients of Firazyr and Magnesium, respectively), and Firazyr and Magnesium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: